DLFY Research

Original investment ideas. Fully transparent. Continuously tracked.

Subscribe to original investment ideas
The First In Vivo CRISPR Approval Is Imminent—And the Market Is Mispricing It by 200%
sectoral·mispricing·4/27/2026

The First In Vivo CRISPR Approval Is Imminent—And the Market Is Mispricing It by 200%

▲+0.00%since publication
Panama Canal Auction Slots Hit $1M as Hormuz Rerouting Drives Demand
commodities·mispricing·4/26/2026

Panama Canal Auction Slots Hit $1M as Hormuz Rerouting Drives Demand

▼-0.50%since publication
Four April Events That Split Big Pharma Into Winners With Durable Moats and Losers Facing Commoditization
sectoral·mispricing·4/26/2026

Four April Events That Split Big Pharma Into Winners With Durable Moats and Losers Facing Commoditization

▲+0.12%since publication
The DOE's '3 by 33' Uranium Squeeze: How Defense Production Act Funding Will Re-Rate US Nuclear Fuel Producers
commodities·anticipated catalyst·4/25/2026

The DOE's '3 by 33' Uranium Squeeze: How Defense Production Act Funding Will Re-Rate US Nuclear Fuel Producers

▲+1.85%since publication
Copper Supply Crunch Mispriced: Long Copper Majors, Fade Base-Metal Diversifieds
commodities·mispricing·4/25/2026

Copper Supply Crunch Mispriced: Long Copper Majors, Fade Base-Metal Diversifieds

▼-0.65%since publication
Hormuz Closure Endgame: Long Energy Logistics, Short Exposed Container Shippers
geopolitics·conditional·3/26/2026

Hormuz Closure Endgame: Long Energy Logistics, Short Exposed Container Shippers

▲+4.79%since publication